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The present study examined the comparative distribution of 5-HTIA receptor mRNA and 5-HTIA receptors in rat brain using a combi- 
nation of in situ hybridisation histochemistry and in vitro receptor autoradiography. 5-HT IA mRNA was visualised using a 910 bp cRNA 
probe synthesised from a BalI-PvulI fragment of the rat 5-HT ~A reetor gene, while 5-HT~A receptors were labelled with the 5-HT~A-selec- 
tive ligand 8-OH-DPAT. In general terms, there was a complementary distribution of cells expressing 5-HT ~A receptor mRNA and 5-HT1A 
receptor sites. High levels of both 5-HTIA mRNA and 5-HT~A receptors were evident in the hippocampal formation (CA1, CA3, dentate 
gyrus), entorhinal cortex, and raphe nuclei and lower levels in neocortex and thalamus. Although 5-HT 1A mRNA was not expressed in any 
regions which did not also exhibit 5-HTIA receptors, within both the diagonal band and the medial septal nucleus mRNA levels were pro- 
portionately higher than 5-HT~A receptor levels, possibly reflecting receptor transport or a heterogeneity in 5-HT ~A receptor turnover mech- 
anisms. 5-HT~A receptor mRNA and 5-HTtA binding sites were undetectable in caudate/putamen and cerebeilar regions. The present data 
indicate the synthesis of 5-HTIA receptors both in raphe serotonergic cells and anatomically specific serotonergic projection areas, further 
supporting both a presynaptic autoregulatory and postsynaptic modulatory role for this receptor in serotonergic transmission. 
INTRODUCTION 
The midbrain raphe nuclei are the source of  wide- 
spread serotonergic innervation throughout  the brain 3 
and serotonin (5-HT) is implicated in a diversity of  phys- 
iological processes including thermoregulation, appetite, 
memory and sexual behavior 16. Moreover ,  a large body 
of  evidence supports a pathophysiological role for sero- 
tonergic dysfunction in anxiety and depressive disor- 
ders 5'6'9. Based on ligand binding studies, 4 pharmaco- 
logically distinct populations of  5-HT receptors have been 
identified in the CNS; 5-HT1, 5-HT 2, 5-HT3, and 
5-HT415. Complex displacement of  [3H]5-HT binding by 
spiperone 19 first confirmed the heterogeneity of 5-HT~ 
sites which have subsequently been classified into at least 
4 receptor subtypes: 5-HTIA , 5-HTIB, 5-HT1¢ , and 
5-HTID 12 
The development of  selective molecules for the 
5-HTIA receptor has allowed identification of  this site as 
both a putative inhibitory somato-dendritic autoreceptor  
on raphe serotonergic cells and as a postsynaptic recep- 
tor in selective serotonergic terminal fields 1°. In addi- 
tion, anxiolytic 24 and antidepressant 2° actions of 5-HT1A- 
selective compounds have generated much interest in 
this receptor in relation to both its role in general limbic 
function and possible involvement in the pathophysiol- 
ogy of  depressive illness. 
Recently, Albert  and colleagues reported the cloning 
and functional characterisation of  the rat 5-HTIA recep- 
tor gene 1. In common with other members of  the G 
protein-coupled receptor family, the 5-HTIA gene exhib- 
its an intronless open reading frame encoding a protein 
with 7 putative transmembrane domains possessing both 
N-linked glycosylation sites in the N-terminal domain 
and potential phosphorylation sites in the third cytoplas- 
mic loop. Here,  we describe the anatomical distribution 
of  cells in rat brain expressing 5-HTIA m R N A  using in 
situ hybridisation histochemistry (ISSH) and compare 
this distribution to that of  radiolabelled 5-HT1A recep- 
tor sites. 
Correspondence: D.T. Chalmers, Mental Health Research Institute, University of Michigan, 205 Washtenaw Place, Ann Arbor, MI 48109, 
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MATERIALS AND METHODS 
Animals 
Male Sprague-Dawley rats (250-300 g) were sacrificed by de- 
capitation, brains were rapidly removed and frozen in liquid isopen- 
tane (-42 °C). Subsequently, brains were sectioned on a cryostat 
maintained at -20 °C and thaw mounted onto polylysine-coated 
microscope slides. Sections were stored at -80 °(2 prior to ISSH and 
in vitro receptor autoradiography. 
Riboprobe production 
A BalI-PvulI fragment of the rat 5-HT1A receptor gene, previ- 
ously reported by Albert and colleagues 1, was ligated into HincII- 
cut pGEM blue (Promega). This fragment is composed of a 910 bp 
insert covering the sequence from the beginning of the second pu- 
tative transmembrane domain to the middle of the extra-cytoplas- 
mic domain found between transmembrane domains VI and VII, 
thus encompassing the entire sequence of the third cytoplasmic 
loop (the region of least homology for the G protein-coupled re- 
ceptor family). Sense and antisense riboprobes were produced by 
linearising the plasmid with appropriate restriction endonucleases 
and transcribing using either SP6 or T7 promoter sites in the pres- 
ence of [35S]UTP (1000 Ci/mmol). 
In situ Hybridisation 
Sections were removed from storage at -80 °(3 and placed di- 
rectly into 4% (v/v) formaldehyde at room temperature. After 60 
min, slides were rinsed in isotonic phosphate buffered saline (2 x 
5 min) and treated with proteinase K (1/~g/ml in 100 mM Tris/HC1, 
pH 8) for 10 min at 37 °C. Subsequently, sections underwent sue- 
cessive rinses in water (1 min), 0.1 M triethanolamine (pH 8, plus 
0.25% acetic anhydride) for 10 min and 2 x SSC (0.3 mM NaCI, 
0.03 mM sodium citrate, pH 7.2) for 5 min. Sections were then de- 
hydrated through graded alcohols and air dried. 
Post-fixed, sections were hybridised with 1.0 x 106 dpm 
[35S]UTP-labelled 5-HTIA riboprobes in hybridisation buffer con- 
taining 75% formamide, 10% dextran sulfate, 3x SSC, 50 mM so- 
dium phosphate buffer (pH 7.4), I x Denhardts solution, 0.1 mg/ml 
yeast tRNA, 0.1 mg/ml sheared salmon sperm DNA and 10 mM 
dithiothreitol in a total volume of 20 jul. Diluted probe was applied 
to sections on a glass coverslip which was sealed into place with 
rubber cement. These sections were then hybridised overnight at 
55 °C. 
Post-hybridisation, the rubber cement was removed and sections 
were washed in 2x SSC for 5 rain. Slides were then treated with 
RNase A (200/zg/ml in 10 mM Tris/HCi, pH 8, containing 0.5 M 
NaCI) for 30 min at 37 °C. Subsequently, sections were washed in 
2x SSC for 10 min, lx  SSC for 10 rain, 0.5x SSC for 60 rain at 
hybridisation temperature (55 °C), 0.5x SSC at room temperature 
for 10 rain and then dehydrated in graded alcohols and air dried. 
For signal detection, sections were either placed on Kodak XAR-5 
X-ray film and exposed for 3 days at room temperature or dipped 
in Kodak NTB-2 emulsion and stored dessicated in light tight boxes 
at 4 °C for 10 days. 
In vitro receptor autoradiography 
[3H]8-OH-DPAT binding was performed according to previously 
published methods TM. Briefly, slide-mounted tissue sections were 
preincubated in 0.17 M Tris/HCl, pH 7.6, containing 4 mM CaCI a 
and 0.1% ascorbic acid for 30 min at room temperature. Subse- 
quently, sections were incubated with 2 nM [3H]8-hydroxy-2-(N,N- 
di-n-propylamino) tetralin) for 60 min at room temperature. Postin- 
cubation, slides were washed in incubation buffer (2 x 5 min) at 
4 °C and dried in a stream of cold air. Non-specific binding was 
determined in the presence of 2 pM 5-HT. Sections were apposed 
to 3H-sensitive Hyperfilm and exposed at room temperature for 7 
days. As 2 nM has previously been determined as a saturating con- 
centration of 8-OH-DPAT ~a, resulting receptor autoradiograms are 
a measure of Bma x for 5-HTjA receptors. 
Microdensitometric analysis 
Autoradiograms generated from ISHH and in vitro receptor au- 
toradiography were analysed using an automated image analysis 
system (Dage camera, MAC II/IMAGE program). Anatomical re- 
gions of interest were interactively selected and mean optical den- 
sity measurements determined from at least 3 coronal sections. For 
ISHH non-specific labelling was measured from an area of section 
in which labelling wasundetectable. Non-specific binding was de- 
termined in adjacent sections incubated with 2/~M 5-HT. 
RESULTS 
Specificity controls 
Probe specificity was confirmed by both hybridising 
sections with labelled sense (mRNA)  5-HTtA probe and 
by treating adjacent sections with RNase (200 mg/ml) 
prior to hybridisation with antisense (cRNA) 5-HT1A 
probe. In both cases the subsequent signal was equiva- 
lent to background (Fig. 1). Non-specific binding of 
[3H]8-OH-DPAT was determined in the presence of 
1000-fold excess 5-HT and amounted to less than 5% of 
total binding. 
Anatomical  distribution 
The comparative anatomical distribution of 5-HT1A 
m R N A  expression and 5-HTIA receptor binding was de- 
termined in adjacent coronal and horizontal brain sec- 
tions. Table I summarises the semi-quantitative analysis 
of both in situ hybridisation autoradiograms and ligand 
binding autoradiograms, while Figs. 2 -6  visually illus- 
trate this analysis. 
Telencephalon 
As can be seen from Figs. 2 and 4, the highest levels 
of 5-HT1A m R N A  expression in the telencephalon were 
observed in the hippocampal formation. However,  within 
this structure the distribution of signal was heteroge- 
neous; very high levels of labelling were evident in the 
pyramidal cell layer of both CA1 and CA3 subfields and 
only low levels in CA2 (Fig. 4). This distribution was 
closely matched by that of 5-HT1A receptor binding (high 
in CA1 and CA3, low in CA2), however, within CA1 
and CA3 subfields 5-HT~A receptor sites were not con- 
fined to pyramidal cell layer but  were also labelled across 
stratum oriens, radiatum and moleculare (Fig. 4B l). In 
a similar fashion, within the dentate gyrus, high levels 
of 5-HT1A m R N A  in the granule cell layer were matched 
by dense labelling of 5-HT1A receptors across both the 
granule cell layer and molecular layer (Fig. 4). 
Within the septum, both lateral and medal nuclei ex- 
hibited very high levels of 5-HT1A m R N A  expression 
(Fig. 3). Similarly, a significant number  of intensely la- 
belled cells were found within the vertical limb of the 
diagonal band (Figs. 3 and 5). However,  with respect to 
5-HT1A receptor binding, it is of interest that both the 
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medial septal nucleus and the diagonal band could be 
characterised by proportionately lower levels of  receptor 
sites than may be expected from 5-HT1A m R N A  levels 
(Table I, Fig. 3). Although low levels of  5-HT1A m R N A  
were expressed in the bed nucleus of  the stria termina- 
lis, 5-HT1A message was undetectable within the cau- 
date-putamen and nucleus accumbens (Fig. 3). 
Within frontal, parietal and temporal regions of  neo- 
cortex, cells expressing 5-HTIA m R N A  were predomi- 
nantly located in deeper cortical layers ( IV-VI) .  In these 
areas, both in situ and receptor binding autoradiograms 
demostrated two distinct bands of complementary label- 
ling (Fig. 3). In contrast, within the archicortical region 
T A B L E  I 
Semiquantitative evaluation of 5-HTIA receptor mRNA and 
5-HTIA binding distribution in various brain regions 
For both ISHH and in vitro receptor autoradiography optical 
densities for each anatomical region were determined as de- 
scribed in Materials and methods. Optical densities for each pa- 
rameter are presented according to their respective percentile 
distributions: + + + +  (>75%), very dense; +++(<75%, >50%), 
dense; ++(<50%, >10%), moderate; +(<10%), low, undetect- 
able. 
Anatomical region 5-HTIA mRNA 5-HTIA binding 
abundance density 
A n t e r i o r  o l fac tory  nuc leus  + + + + 
A m y g d a l a ;  B a s o m e d i a l  nuc leus  + + + + + + 
Cor t ica l  amygda lo id  nuc leus  + + + + + + 
Bed  nuc leus  s t r ia  t e rmina l i s  + + + 
C a u d a t e  nuc leus  - - 
C ingu la te  cor tex  (superf icial)  + + + + + + 
Cingulate cortex (deep) + + +  + + +  
Diagonal band + + + + + + 
Dorsal raphe nucleus + + + + + + + + 
Entorhinal cortex (superficial) + + + + + + + + 
Frontal cortex (superficial) + + + + 
Frontal cortex (deep) + + +  + + +  
F/parietal cortex (superficial) + ++ 
F/parietal cortex (deep) + + + + + 
Hippocampai formation; 
CA1 + + + +  + + + +  
CA2 + + +  ++ 
CA3 + + + +  + + + +  
Dentate gyrus 
(granule/molecular) + + + + + + + + 
Hypothalamus; 
Anterior nucleus + + + + + 
Ventromedial nucleus + + + + + + + 
Inferior colliculus + ++ 
Interpeduncular nucleus + + + + + + + 
Lateral septal nucleus + + +  + + + +  
Medial septal nucleus + + + + + + 
Medial geniculate nucleus + + 
Nucleus accumbens - - 
Raphe magnus nucleus + + + + 
Superior colliculus 
(superficial layer) ++ ++ 
Ventral lateral 
geniculate nucleus + + + + 
Zona incerta ++ + 
of  entorhinal cortex, intensely labelled clusters of 5-HT1A 
m R N A  expressing cells were primarily located in a sin- 
gle superficial lamina (Fig. 4CI), while 5-HT1A receptors 
were labelled across the entire cortical mantle (Fig. 4 C I ) .  
The density of  both 5-HTIA m R N A  and 5-HT1A recep- 
tor sites was relatively homogeneous across cingulate 
cortex. 
Selective nuclei of  the amygdaloid complex, cortical 
amygdaloid nucleus and basomedial amygdaloid nucleus, 
exhibited significant levels of  5-HTxA m R N A .  This dis- 
tribution was closely mathced by the distribution of  
5-HT1A receptor binding (Fig. 4). 
Diencephalon 
In general terms, compared to the telencephalon, few 
regions of  the diencephalon exhibited 5-HTIA m R N A  
expression or receptor binding. Within the thalamus, the 
zona incerta demonstrated moderate levels of  both 
5-HTIA m R N A  and 5-HTIA binding (Fig. 4AI), as did 
the ventral lateral geniculate nucleus. 5-HTIA m R N A  
was undetectable in other major thalamic nuclei. 
In the hypothalamus, the ventromedial and anterior 
hypothalamic nuclei exhibited dense to moderate levels 
of  5-HT1A m R N A ,  respectively (Fig. 4A I, BI). A distri- 
bution mirrored by 5-HTIA receptor binding. With the 
exception of  these nuclei, however, 5-HT~A m R N A  ex- 
pression within hypothalamic regions, including the 
paraventricular nucleus, was unremarkable.  
Mesencephalon 
Both the dorsal and median raphe nuclei of  the mid- 
brain displayed high levels of 5-HT1A m R N A .  Within 
the dorsal raphe, the most intensely labelled cells were 
evident in the more lateral and dorsal aspects of  the nu- 
cleus while signal in the median raphe nucleus was pre- 
dominantly located along the midline (Fig. 6). Both nu- 
clei demonstrated 5-HT1A receptor binding in proportion 
to the level of 5-HTIA m R N A  expression (Fig. 4C1). At  
this level, scattered cells within the inferior colliculus 
demonstrated low levels of  5-HT1A m R N A  (Fig. 4C~), 
while, more rostrally, the superior colliculus also exhib- 
ited low levels of  labelling, predominantly in the super- 
ficial gray layer. Diffuse 5-HTIA binding was evident 
within both areas. Very high levels of 5-HT1A m R N A  
were also expressed in the interpeduncular nucleus, with 
the most densely labelled cells being in the lateral sub- 
nucleus. Again,  this high level of  5-HTIA m R N A  expres- 
sion was matched by high levels of 5-HTIA receptor 
sites. 
Aside from some scattered cells in the lateral lemnis- 
cal nucleus, 5-HT1A m R N A  was undetectable in other 
mesencephalic structures including the substantia nigra 
and ventral tegmental area. 
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Fig. 2. Representative horizontal brain sections illustrating the general complementary distribution of 5-HT LA mRNA and 5-HT1A receptor 
sites. 
Cerebellum, ports and medulla 
Both 5-HT1A receptor mRNA and 5-HT1A receptor 
binding were undetectable in cerebellar cortex. Aside 
from a moderate level of expression in the raphe mag- 
nus nucleus, 5-HT1A receptor mRNA abundance was 
relatively unremarkable in pons and medulla. 
DISCUSSION 
In the present study, the combined use of ISHH and 
in vitro receptor autoradiography has allowed precise an- 
atomical localisation and comparison of cells expressing 
5-HT1A mRNA and 5-HT1A receptor sites. The specific- 
ity of the hybridisation signal was confirmed by both the 
absence of specific labelling in sections incubated with 
sense 5-HT1A probe and the abolition of specific signal 
after pretreatment of tissue sections with RNase. In ad- 
dition, the heterogeneous distribution of 5-HT1A mRNA 
within the brain and the absence of specific signal in an- 
atomical regions of high cell density, such as cerebellum, 
argues in favour of probe specificity. It is of interest that 
Albert et al.1 have previously reported the existence of 
3 distinct mRNA species for the rat 5-HT1A receptor as 
other G protein-coupled receptors (including the human 
5-HT1A receptor) have been shown to express only one 
form of mRNA. The functional significance of this phe- 
nomenon is, at present, unknown. However, the rat 
5-HT1A receptor gene is intronless and it is likely that 
the 3 mRNA species result from different transcriptional 
start sites or polyadenylation sites. In the present ISHH 
study we have employed specific cRNA probes which 
recognise all 3 mRNA species. 
In general terms, the results of the present study in- 
dicate a broad complementary distribution of cells ex- 
pressing 5-HTIA mRNA and 5-HTxA receptor sites. High 
levels of mRNA were found in hippocampus, dentate 
56 
gyms, septal nuclei, entorhinal cortex and raphe nuclei. 
In agreement with previous autoradiographic studies 1°' 
:8, these areas also exhibited moderate to high densities 
of  5-HT1A receptor sites. Lower levels of  both m R N A  
expression and 5-HT:A binding were evident in neocor- 
tex, hypothalamus and thalamus. However,  although 
there was a macroscopic concordance of  m R N A  and re- 
ceptor sites throughout the brain, subtle differences were 
evident within specific anatomical regions. Within hip- 
pocampus, 5-HTIA m R N A  was exclusively located in the 
pyramidal cell layer of CA1 and CA3 subfields, while 
5-HT:A receptors were found in high density across stra- 
tum oriens, radiatum and moleculare in these subfield 
(Fig. 4). Such a differential distribution can, however, 
be rationalised in cytoarchitectural terms. Within these 
fields, pyramidal cells are characterized by possessing 
two main groups of  dendrites; the apical, extending 
through the radiatum layer to the stratum lacanosum 
moleculare and the basal, branching into the stratum 
oriens 4. Thus it would seem likely that 5-HT:A receptors 
Fig. 3. Rostro-caudal (A-C) distribution of 5-HTIA mRNA (left 
hemisphere) and 5-HTtA receptors (right hemisphere) in represen- 
tative coronal brain sections. Fcx, frontal cortex; AON, anterior 
olfactory nucleus; LS, lateral septal nucleus; MS, medial septal nu- 
cleus; VDB, vertical diagonal band. All images were generated 
from X-ray film. 
I 
J 
Fig. 4. Rostro-caudal (AI-C I) distribution of 5-HTIA mRNA (left 
hemisphere) and 5-HTIA receptors (right hemisphere) in represen- 
tative coronal sections. CA1, field CA1 (Ammons horn); CA3, 
field CA3 (Ammons horn); DG, dentate gyrus; ZI, zona incerta; 
AH, anterior hypothalamic nucleus; BA, basolateral amygdaloid 
nucleus; Pir, piriform cortex; IC, inferior colliculus; DR, dorsal ra- 
phe nucleus; MR, median raphe nucleus; EnCx, entorhinal cortex. 
All images were generated from X-ray film. 
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Fig. 5. Dark-field photomicrographs of cells hybridised with [3SS]cRNA 5-HTlA probe in (A) lateral septal nucleus (LS) and (B) vertical 
diagonal band (VDB). Bar = 100/,m. 
Fig. 6. Dark-field photomicrographs of cells hybridised with [35S]cRNA 5-HTtA probe in (A) dorsal raphe nucleus (DR) and (B) median 
raphe nucleus (MR). In A, note the high density of silver grains within cells in the more dorso-lateral aspect of the nucleus. In B, cells are 
hybridised along the midline. Bar = 60 pm. Note the high level of the anatomical resolution obtained in raphe nuclei from emulsion dipped 
sections in comparison to that obtained from X-ray generated images (Fig. 4). 
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synthesised in hippocampal pyramidal cell bodies are 
subsequently transported along both apical and basal 
dendrites prior to insertion into the neuronal membrane. 
In a similar fashion, 5-HT:A receptors transcribed within 
the granule cell layer of the dentate gyrus appear to be 
transported to granule cell denritic fields in the molecu- 
lar layer prior to insertion. While it may be feasible that 
a proportion of 5-HT1A receptors could be located on 
afferent fibers to the hippocampus, both lesion studies 11 
and electrophysiological data 12 indicate that hippocam- 
pal 5-HTIA sites mediate postsynaptic responses to sero- 
tonergic input. The present data confirm the intrahip- 
pocampal synthesis of 5-HT1A receptors, supporting a 
postsynaptic localisation. 
In contrast to the hippocampus, within midbrain ra- 
phe nuclei 5-HTIA receptors appear to be presynapti- 
cally located. Aghajanian and colleagues have shown 
that iontophoretic application of 5-HTIA agonists onto 
raphe nuclei results in reduced firing of serotonergic neu- 
rons 21, suggesting an autoregulatory function for 5-HTIA 
sites in this region. In keeping with these findings, the 
presence of 5-HT1A mRNA and 5-HTIA receptors in ra- 
phe nuclei strongly suggests a local synthesis and so- 
mato-dendritic localisation. Indeed, in agreement with 
the cytoarchitecture of the DR nucleus 23, higher levels 
of both 5-HT1A mRNA expression and 5-HT1A binding 
were evident in the lateral and dorsal aspects of the nu- 
cleus where the larger serotonin-producing cells are lo- 
cated. Interestingly, 5-HT1A receptor mRNA has also 
been identified within raphe neurons 14 indicating that 
5-HT~A receptors may also subserve an autoregulatory 
function on serotonergic neurons. In the present study 
neuronal signal was identified by thionin staining. How- 
ever, it is feasible to differentiate glial from neuronal 
signal by combining glial-specific immunocytochemical 
markers with in situ hybridisation. Such double labelling 
techniques could, however, produce false negative re- 
sults where low abundance mRNA species are concerned 
due to the quenching of in situ signal by the immuno- 
labelling. 
5-HTIA receptor mRNA was not found in any ana- 
tomical regions which did not exhibit 5-HTIA receptor 
binding. However, the level of 5-HT1A mRNA expres- 
sion within any given anatomical region was not always 
directly related to the density of 5-HT1A receptors in 
that region. This was the case in both the medial septal 
nucleus and the vertical diagonal band where, in com- 
parison to other areas examined, mRNA levels were 
proportionately higher than receptor binding densities. 
Such a discrepancy may be explained in technical terms 
as ISHH using 35S-labelled probes affords increased sen- 
sitivity as compared to 3H-radioligands. It is also true 
that 3H-radioligands are susceptible to tissue quenching 
artifacts which may compromise optical density measure- 
ments. However, given the anatomical specificity, it is 
possible that this disproportionality may reflect a specific 
neurobiological process, perhaps related to transport of 
the receptor protein to sites distant from the cell body 
transcribing the receptor mRNA or possibly related to 
5-HTIA receptor turnover mechanisms in these particu- 
lar nuclei. The fact that both these areas are charac- 
terised by high densities of cholinergic cells adds some 
credibility to the possibility that 5-HT1A receptors may 
be differentially regulated within different cell popula- 
tions. 
Serotonin is implicated in mood, behaviour and mem- 
ory effects 6'16, central functions related to the limbic sys- 
tem. It is evident from the present study that the high- 
est levels of 5-HT1A mRNA expression are found in 
limbic structures; hippocampus, septum, entorhinal cor- 
tex, suggesting an important role for these sites in lim- 
bic circuits. In this respect, the anxiolytic and antide- 
pressant effects of 5-HT1A-selective compounds 20'24 
indicates that 5-HT~A receptor dysfunction may contrib- 
ute to 5-HT~A-associated affective disorders. Such a sce- 
nario is further suported by the ability of both tricyclic 
antidepressants and 5-HT uptake inhibitors to alter 
5-HT1A receptor numbers 25. The ability of these drugs 
to alter 5-HTIA mRNA expression remains to be inves- 
tigated. 
Serotonin is also known to influence a number of hy- 
pothalamic associated functions such as sleep, thermoreg- 
ulation and neuroendocrine function. In this respect, 
multiple lines of evidence indicate that serotonin exerts 
a modulatory effect on the hypothalamic-pituitary-ad- 
renal (HPA) system 2"7. In particular, activation of 
5-HT1A receptors has been shown to induce corticotro- 
pin (ACTH) and corticosteroid release in both rodents s 
and human subjects 17, an effect antagonised by (-)-pin- 
dolol 8, a stereoselective 5-HT1A/m blocker. Although it 
is apparent that 5-HT1A receptor activation regulates 
HPA function, the mechanism of action is unclear. One 
obvious possibility would be 5-HT~A receptor mediated 
modulation of corticotropin-releasing hormone (CRH)- 
synthesizing neurons in the paraventricular nucleus of 
the hypothalamus, which, via the action of CRH, would 
result in increased ACTH and corticosteroid release. 
However, the lack of 5-HTIA mRNA in the PVN in the 
present study argues against 5-HT~A receptor synthesis 
in CRH neurons, suggesting that the site of action is not 
within the PVN. This raises the possibility that the mod- 
ulatory effects of 5-HT:A agonists are circuit mediated, 
possibly acting on other hypothalamic nuclei which sub- 
sequently project to PVN (anterior hypothalamic or ven- 
tromedial nuclei) 22 or on extra-hypothalamic structures. 
A hippocampal-bed nucleus-PVN circuit is stronlgy im- 
plicated in negative feedback control  of  cor t icosteroid 
release 13 and could,  theoret ical ly ,  represent  the mecha-  
nism of  action for 5-HT~A receptor  med ia ted  H P A  mod-  
ulation as both  5-HT1A receptor  m R N A  and 5-HT1A re- 
ceptors  were evident  in the h ippocampus  and bed  
nucleus. 
The present  results using I S H H  are general ly consis- 
tent  with Nor thern  blot  analysis of  5-HT~A receptor  
m R N A  in rat  brain showing the highest levels of  m R N A  
in h ippocampus  and septum and lowest in hypothalamus  
and basal  ganglia 1. However ,  the added  sensitivity and 
anatomical  resolut ion of  I S H H  has al lowed identif icat ion 
of cells expressing 5-HT~A m R N A  in areas undetec table  
by Nor thern  analysis, such as raphe  nuclei and neocor-  
tex, and within cell groups in any anatomical  region (e.g. 
pyramidal  cells of  CA1,  CA3) .  In view of  the impor tance  
of s tructure/function relat ionships in the brain,  the abil- 
ity to precisely localise cells expressing a given receptor  
type allows more  insight into the putat ive function of  the 
receptor  within CNS circuits. Moreover ,  in combinat ion  
with in vitro receptor  au torad iography ,  I S H H  provides 
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